Dr. Christian, who achieved major advances in the pathogenesis of rheumatoid arthritis and in systemic lupus erythematosus (SLE), was beloved by colleagues, trainees, and friends throughout the United States and around the world.
Dr. Alonso is currently the George F. and Sybil H. Fuller Term Chair in Diabetes and Director of Beta Cell Biological Studies at the University of Massachusetts Medical School.
Dr. Shin’s project will be part of the initiative’s effort to expand learning and research opportunities in New York City for faculty and students, and will complement work in Ithaca during the 2019-20 academic year.
Five winners in the Weill Department of Medicine have been selected to receive Fund for the Future awards to pursue a wide range of breakthrough research.
Dr. Sharaiha will oversee a newly expanded interventional group, as well as advanced endoscopy training at the NewYork-Presbyterian's Greenberg Pavilion and David H. Koch Center.
Building upon the division’s strong legacy in the field of Inflammatory Bowel Disease (IBD), Dr. Longman will oversee and expand clinical, research and educational activities at the JRC.
This year’s group of interns include 24 women and 21 men who hail from a total of 30 different top tier medical schools including 6 from Weill Cornell Medical College.
A premier investigator in the areas of translational and clinical drug development, Dr. Hidalgo has been at the helm of the early clinical development of more than 50 new anticancer agents.
The ongoing program of interdisciplinary and multilevel mentoring teams will meet twice more in the spring of 2019; four meetings will be held during the 2019-2020 academic year.
The event was open to students, trainees and professionals in the fields of medicine, nursing, physician’s assistant, social work, administration, and more.